|
I'm also excited to share that Dr Christina Coughlin, Chief Medical Officer and Executive Vice President, Tmunity will be joining us at the event. Tmunity has an executive board of unrivalled expertise including Carl June, MD; Bruce Blazar, MD; Bruce Levine, PhD; Yangbing Zhao, MD, PhD; Jim Riley, PhD; and Anne Chew, PhD and it has been named as one of the key biotechs to watch.
Tmunity gives very few public presentations and the congress will provide a unique opportunity to hear first-hand the novel data on PSMA CAR-T and how Tmunity is developing CAR-T switches to regulate T cell activation and direction in vivo.
Dr Coughlin will be joining Dr Alessandro Riva, Executive Vice President, Oncology Therapeutics Gilead, Dr Leonard Lichtenfeld, Acting Chief Medical Officer, American Cancer Society to determine how we effectively edit T cells at scale, and how the industry is pushing for patient access to accelerate your CAR-T pipelines.
|
